These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20035078)

  • 1. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
    Barr TL; Latour LL; Lee KY; Schaewe TJ; Luby M; Chang GS; El-Zammar Z; Alam S; Hallenbeck JM; Kidwell CS; Warach S
    Stroke; 2010 Mar; 41(3):e123-8. PubMed ID: 20035078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An MRI Hyperintense Acute Reperfusion Marker Is Related to Elevated Peripheral Monocyte Count in Acute Ischemic Stroke.
    Nadareishvili Z; Luby M; Leigh R; Shah J; Lynch JK; Hsia AW; Benson RT; Latour LL
    J Neuroimaging; 2018 Jan; 28(1):57-60. PubMed ID: 28722240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke.
    Batra A; Latour LL; Ruetzler CA; Hallenbeck JM; Spatz M; Warach S; Henning EC
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1188-99. PubMed ID: 20197780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
    Kamada H; Yu F; Nito C; Chan PH
    Stroke; 2007 Mar; 38(3):1044-9. PubMed ID: 17272778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke.
    Ostwaldt AC; Rozanski M; Schaefer T; Ebinger M; Jungehülsing GJ; Villringer K; Fiebach JB
    Eur Radiol; 2015 Nov; 25(11):3161-6. PubMed ID: 25899419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
    Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS
    J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
    Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
    Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.
    Fujimura M; Gasche Y; Morita-Fujimura Y; Massengale J; Kawase M; Chan PH
    Brain Res; 1999 Sep; 842(1):92-100. PubMed ID: 10526099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption.
    Warach S; Latour LL
    Stroke; 2004 Nov; 35(11 Suppl 1):2659-61. PubMed ID: 15472105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S; Planz O; Schwaninger M
    Cerebrovasc Dis Extra; 2016; 6(2):50-9. PubMed ID: 27560521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
    Grossetete M; Phelps J; Arko L; Yonas H; Rosenberg GA
    Neurosurgery; 2009 Oct; 65(4):702-8. PubMed ID: 19834375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
    Sarami Foroshani M; Sobhani ZS; Mohammadi MT; Aryafar M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3053-3065. PubMed ID: 30093209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury.
    Wu Y; Wang YP; Guo P; Ye XH; Wang J; Yuan SY; Yao SL; Shang Y
    J Mol Neurosci; 2012 Mar; 46(3):483-91. PubMed ID: 21845429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome.
    Brouns R; Wauters A; De Surgeloose D; Mariën P; De Deyn PP
    Eur Neurol; 2011; 65(1):23-31. PubMed ID: 21135557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion.
    Zhu M; Xing D; Lu Z; Fan Y; Hou W; Dong H; Xiong L; Dong H
    Neurosci Res; 2015 Jul; 96():14-9. PubMed ID: 25630038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.
    Rosenberg GA; Cunningham LA; Wallace J; Alexander S; Estrada EY; Grossetete M; Razhagi A; Miller K; Gearing A
    Brain Res; 2001 Mar; 893(1-2):104-12. PubMed ID: 11222998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage.
    Abilleira S; Montaner J; Molina CA; Monasterio J; Castillo J; Alvarez-Sabín J
    J Neurosurg; 2003 Jul; 99(1):65-70. PubMed ID: 12854746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
    Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
    Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.
    Ji B; Zhou F; Han L; Yang J; Fan H; Li S; Li J; Zhang X; Wang X; Chen X; Xu Y
    Transl Stroke Res; 2017 Aug; 8(4):334-340. PubMed ID: 28243834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.